Related by context. All words. (Click for frequent words.) 73 HPV strains 72 human papillomavirus HPV 70 vaginal cancers 69 HPV 69 HPV# 67 cervical cancers 66 human papillomavirus 65 anal cancers 65 HPV infections 65 genital warts 65 oncogenic HPV types 65 HPV infection 65 HPVs 64 serotypes 63 HPV subtypes 63 HPV-#/# 62 external genital lesions 62 human papilloma virus 62 Human Papilloma Virus 61 vaccine serotypes 61 genital wart cases 61 cervical lesions 61 serogroups 61 HPV genotypes 61 quadrivalent vaccine 61 Human Papillomavirus HPV 61 pneumococcal serotypes 60 sexually transmitted HPV 60 HCV infection 60 cervical vaginal 60 pneumococcus 60 penile cancers 60 Human Papillomavirus 60 S. pneumoniae 60 Chlamydia trachomatis 59 vaginal lesions 59 vulvar cancers 59 cervical vulvar 59 HPV Types 59 Human Papilloma Virus HPV 59 precancerous lesions 59 viral subtypes 59 varicella zoster virus 59 precancerous cervical lesions 59 Streptococcus pneumoniae 59 Gardasil protects 59 CMV infection 59 invasive pneumococcal disease 59 Trichomonas vaginalis 58 cervical intraepithelial neoplasia 58 nonvaccine 58 CMV disease 58 invasive cervical cancer 58 sexually transmitted human papillomavirus 58 pneumococcal strains 57 S. aureus infections 57 parainfluenza virus 57 pneumococcal bacteria 57 Human papillomavirus HPV 57 pre cancerous lesions 57 adenocarcinomas 57 severe rotavirus gastroenteritis 57 pneumococcal infection 57 squamous cell carcinomas 57 cervical cancer genital warts 56 Epstein Barr virus EBV 56 GARDASIL 56 precursor lesions 56 ovarian cancers 56 nonvaccine serotypes 56 CIN2 + 56 VZV 56 lymphomas 56 Chlamydia infection 56 colorectal cancers 56 breast cancers 56 herpes simplex virus 56 human papillomaviruses HPV 56 varicella zoster virus VZV 56 Candida species 56 antibody responses 56 human herpesvirus 56 serogroup 56 oncogenic HPV 56 neutralizing antibodies 56 grade cervical intraepithelial 55 human papillomaviruses 55 chlamydial infection 55 serotype #A 55 grade cervical dysplasia 55 lung cancers 55 Menveo 55 basal cell carcinoma BCC 55 genital herpes infections 55 dysplastic lesions caused 55 Vaccine Recombinant 55 serogroup B 55 CIN2 55 GARDASIL ® 55 invasive meningococcal disease 55 wart virus 55 Human papilloma virus 55 risk HPV genotypes 55 N. meningitidis 55 LTBI 54 Mycobacterium tuberculosis 54 basal cell carcinomas 54 S. aureus isolates 54 Plasmodium falciparum 54 BRCA2 mutations 54 abnormal pap smears 54 HPV sexually transmitted 54 rotavirus gastroenteritis 54 nucleoside analogues 54 serogroup C 54 nonmelanoma skin cancers 54 HCV genotypes 54 vector adenovirus serotype 54 genital lesions 54 vulvar cancer 54 precancers 54 Cervista HPV HR 54 ovarian tumors 54 HPV Human Papillomavirus 54 ano genital warts 54 cancers 54 Human papillomavirus 54 vulvar 54 Haemophilus influenza 54 human papilloma viruses 54 MGUS 54 bacterium Neisseria meningitidis 54 Plasmodium vivax 54 pneumococci 54 Staphylococcus aureus infections 54 bladder cancers 54 genital tract 54 EGFR mutations 54 prostate cancers 54 oropharyngeal cancer 53 advanced adenomas 53 E7 proteins 53 Neisseria gonorrhoeae 53 endometrial cancers 53 valent vaccine 53 NNRTI resistance 53 Escherichia coli Klebsiella pneumoniae 53 preventing precancerous lesions 53 cervical dysplasia 53 herpes zoster 53 papilloma virus 53 dengue viruses 53 quadrivalent HPV vaccine 53 colon cancers 53 Human Papillomavirus Quadrivalent Types 53 genital ulcers 53 GISTs 53 Strep bacteria 53 herpesviruses 53 seronegative 53 Genital herpes 53 HCV genotype 53 ALK mutations 53 pancreatic cancers 53 rotavirus infection 53 CIN3 + 53 mesotheliomas 53 cancerous cervical lesions 53 BRCA mutation 53 penile anal 53 genes BRCA1 53 antibody titers 53 osteosarcomas 53 clade B 53 cervical cancer 53 chlamydia trachomatis 53 BRAF gene 53 pneumococcal infections 53 skin cancers 52 squamous cell cancers 52 Novartis MenB vaccine 52 HBV infection 52 medulloblastoma 52 herpes viruses 52 FGFR2 52 valent pneumococcal conjugate vaccine 52 ALCL 52 elevated CRP 52 advanced adenoma 52 hepatitis C virus 52 Recombinant Vaccine 52 vulvar lesions 52 HGPIN 52 genital HPV infection 52 UVA radiation 52 N. gonorrhoeae 52 prophylactic vaccines 52 renal cell carcinomas 52 enteroviruses 52 chronic HBV infection 52 4CMenB 52 cervical adenocarcinoma 52 BRCA mutations 52 serotype 52 Adhibit 52 atypical hyperplasia 52 b Hib 52 cytomegalovirus 52 neutralizing antibody responses 52 HLA B# 52 medulloblastomas 52 entecavir 52 highly immunogenic 52 humanized monoclonal antibody 52 HPV infects 52 bowel cancers 52 invasive cervical cancers 52 H. pylori 52 malignant melanomas 52 papillomaviruses 52 HPV human papillomavirus 52 HER2/neu 52 sarcomas 52 CERVARIX 52 meningococcus 52 EGFRvIII 52 malignancies 52 rotavirus 52 anal HPV 52 Conjugate Vaccine 52 Epstein Barr virus 52 autoantibodies 52 human papilloma 52 invasive ductal 52 Zolinza 52 VivaGel TM 52 hereditary breast cancer 52 K#R [002] 51 cytomegalovirus CMV 51 S. aureus bacteria 51 neutralizing antibody 51 pertussis tetanus 51 Streptococcus pneumonia 51 HPV vaccine protects 51 HER2 positive breast cancer 51 superinfection 51 breast carcinomas 51 Cryptococcus neoformans 51 TGFBR1 * 6A 51 L. pneumophila 51 malignant lesions 51 bacteria Pseudomonas aeruginosa 51 methicillin susceptible Staphylococcus aureus 51 BRAF protein 51 fluoroquinolone resistance 51 meningococcal bacteria 51 PARP inhibitor 51 Hepatitis C virus 51 liver metastases 51 mutated BRCA1 51 causes genital warts 51 pneumococcal disease 51 vaginitis 51 virulence genes 51 Neisseria meningitidis serogroups 51 abnormal Pap smears 51 papillomavirus 51 pathogenic strains 51 oral herpes 51 contralateral breast 51 Salmonella typhi 51 carcinomas 51 NNRTIs 51 hepatitis C HCV 51 sexually transmitted human papilloma 51 KRAS mutations 51 genital HPV 51 GBM tumors 51 neoplasias 51 rotaviruses 51 tumor recurrence 51 HER2 overexpression 51 colorectal tumors 51 Streptococcus pyogenes 51 tigecycline 51 5 6A 6B 51 Cervista HPV 51 bacteria Streptococcus pneumoniae 51 metastatic lesions 51 genital wart 51 human papillomavirus HPV vaccine 51 HBV 51 mycophenolate mofetil 51 Streptococcus pneumoniae bacteria 51 staphylococcal infections 51 GlaxoSmithKline Cervarix 51 4 6B 9V 51 endometrial hyperplasia 51 Tindamax R 51 NRTI resistance 51 nonmelanoma skin cancer 51 indinavir 51 hemagglutination inhibition 51 ASCUS 51 Hib disease 51 ROTARIX 51 methicillin susceptible 51 UVB radiation 51 cryptococcosis 51 hMPV 51 Ad5 51 adenoma 51 conjugate vaccine 51 cervical breast 51 epithelial tumors 51 neuroblastoma tumors 51 locoregional recurrence 51 Helicobacter pylori H. pylori 51 hepatitis C genotype 51 pneumococcal diseases 51 preventing genital warts 51 urethritis 51 RSV infection 50 BRCA1 gene 50 papilloma 50 premenopausal breast cancer 50 herpes zoster virus 50 leukaemias 50 bacterial vaginosis 50 bacterial strains 50 invasive breast cancer 50 B7 H3 50 hepatitis B virus HBV 50 BRCA1 mutation carriers 50 ovarian breast 50 vaccinees 50 GABHS 50 S. aureus 50 endometrial ovarian 50 IgM antibodies 50 Ankara MVA 50 Human Papilloma 50 pelvic inflammatory disease 50 chlamydial infections 50 CXCR4 50 HCV infections 50 WT1 50 BRAF mutation 50 efavirenz Sustiva 50 CERVARIX ® 50 prostate pancreatic 50 FLT3 50 vulvar vaginal 50 cell lymphomas 50 Twinrix 50 pneumoniae 50 seroconversion 50 quadrivalent 50 mtDNA mutations 50 LSIL 50 BRCA2 mutation 50 oropharyngeal cancers 50 BRCA2 mutation carriers 50 HER2 gene 50 uterine cancers 50 EGFR mutation 50 gastric adenocarcinoma 50 opportunistic pathogens 50 bone metastasis 50 Acute lymphoblastic leukemia 50 thyroid cancers 50 neuroblastomas 50 Basal cell carcinoma 50 Staph aureus 50 K ras mutations 50 IGF 1R 50 cervical precancerous lesions 50 cervical cancer precancerous 50 BRCA1 mutations 50 ZOSTAVAX 50 chronic HCV infection 50 anogenital warts 50 C. trachomatis 50 S. aureus infection 50 falciparum 50 Kaposi sarcoma 50 precancerous cervical 50 Cervarix 50 febrile seizures 50 multidrug resistant strains 50 viral strains 50 HBeAg negative 50 Neisseria meningitidis 50 premalignant 50 gene mutations 50 histologies 50 recurrent VTE 50 spontaneous preterm delivery 50 human papillomavirus sexually transmitted 50 antibodies 50 prophylactic vaccine 50 breast carcinoma 50 estrogen progestin therapy 50 seroprotection 50 MenACWY CRM 50 anal lesions 50 staphylococci 50 chlamydial 50 diphtheria tetanus pertussis 50 ductal cancer 50 vaccine Menactra 50 mutations 50 Helicobacter 50 genital ulcer disease 50 pneumococcal illnesses 50 candidemia 50 causes chickenpox 50 osteoporotic fractures 50 circulating rotavirus 50 Ixiaro 50 P. falciparum 50 anogenital 50 pneumococcal 50 HSV1 50 infectious microorganisms 50 basal cell nevus syndrome 50 invasive carcinoma 50 abnormal cytology 50 asymptomatic carriers 50 simplex virus 50 dysplastic lesions 49 enterotoxigenic E. coli 49 HIV1 49 breast ovarian 49 actinic keratosis 49 protease inhibitors PIs 49 PREVNAR 49 Velcade bortezomib 49 ROTATEQ 49 uPAR 49 MenACWY 49 neoplasia 49 neuroendocrine tumors 49 oral poliovirus 49 bacterium Chlamydia trachomatis 49 esophageal cancers 49 breast tumors 49 topical microbicide 49 Herpes simplex virus 49 BRAF mutations 49 Cytomegalovirus CMV 49 UGT#A# 49 HER2 49 dasatinib 49 familial ALS 49 anal penile 49 invasive candidiasis 49 Haemophilus influenzae 49 HSV2 49 replicon 49 cutaneous squamous cell carcinoma 49 vaccine Zostavax 49 polysaccharide vaccines 49 metastatic prostate 49 HPV vaccines 49 periodontal infection 49 Staph bacteria 49 invasive ductal carcinomas 49 coinfection 49 PCV1 49 rhinovirus 49 melanomas 49 endogenous estrogen 49 MenB 49 KINRIX 49 Uterine fibroids 49 HER2 positive cancers 49 prostate specific 49 malignant polyps 49 ovarian pancreatic 49 CMV infections 49 Cervical cancer 49 Thyroid nodules 49 ESBLs 49 papillomas 49 human metapneumovirus 49 epithelial cancers 49 tumor subtypes 49 micrometastases 49 T#I [002] 49 Hepsera 49 E. faecalis 49 MRSA isolates 49 axillary lymph nodes 49 Her2 49 BRCA2 49 prostate cancer CaP 49 Nonoxynol 9 49 allergic asthma 49 grade gliomas 49 abnormal Pap tests 49 hormone receptor negative 49 VUR 49 multidrug resistance 49 Genital warts 49 Hepatitis B virus 49 recombinant vaccine 49 EUS FNA 49 penile cancer 49 HCMV 49 inherited mutations 49 infectious mononucleosis 49 MDRSP 49 sexually transmitted 49 PPSV 49 ZNF# 49 MCV4 49 endocrine tumors 49 pre cancerous 49 PCV# 49 soft tissue sarcomas 49 myeloproliferative diseases 49 bacterium Streptococcus pneumoniae 49 quadrivalent human papillomavirus 49 mutated KRAS gene 49 nonsense mutations 49 Menactra 49 VivaGel ™ 49 PREVENAR 49 solar keratosis 49 CERVARIX R 49 hamartomas 49 colon tumors 49 neoplasms 49 PCa 49 HER2 receptor 49 Gardasil vaccine protects 49 staphylococcus bacteria 49 grade cervical lesions 49 CCR5 tropic HIV 49 fungal organisms 49 pneumococcal pneumonia 49 lung adenocarcinoma 49 raltegravir 49 NF kB pathway 49 rhinovirus infection 49 trastuzumab Herceptin 49 basal cell cancers 49 distant metastasis 49 hypermethylation 49 lobular cancer 49 systemic scleroderma 49 Pap smear screening 49 poliovirus vaccine 49 Chlamydia pneumoniae 49 grade dysplasia 49 Basal cell 49 candida infections 49 parainfluenza 49 M. bovis 49 anastrozole 49 trivalent influenza vaccine 48 Haemophilus influenza type 48 trans retinoic acid 48 myelofibrosis polycythemia vera 48 Candida infection 48 respiratory viruses 48 HIV seronegative 48 Staphylococcus aureus bacteria 48 invasive pneumococcal diseases 48 coagulase negative staphylococci 48 HC2 test 48 BRCA mutation carriers 48 malarial parasites 48 SHBG levels 48 genetic alterations 48 BRCA1 mutation 48 herpes simplex 48 Serotype 48 HMGA2 48 uveal melanoma 48 venous blood clots 48 S.aureus 48 cervical HPV 48 myeloproliferative disorders 48 rebleeding 48 candidiasis 48 pre malignant lesions 48 Staphylococcus aureus 48 respiratory viral infections 48 adenomatous polyps 48 basal cell carcinoma 48 Zyclara Cream 48 H pylori 48 NNRTI resistant virus 48 follicular lymphoma 48 chronic HBV 48 lobular carcinoma 48 mycobacterium 48 gastric cancers 48 hepatocellular carcinoma HCC 48 intravenous bisphosphonates 48 PCA3 48 subtype 48 coinfected 48 trastuzumab 48 NNRTI 48 Synflorix 48 renal toxicity 48 trivalent vaccine 48 FluCAM arm 48 GIST tumors 48 signal transduction inhibitors 48 micafungin 48 H. pylori infection 48 HbF 48 pertuzumab 48 K#N 48 NRTIs 48 prostate lung 48 varicella infection 48 rotavirus strains 48 BRSV 48 Wolbachia 48 medullary thyroid cancer 48 clade C 48 streptococcus pneumoniae 48 Epstein Barr Virus EBV 48 Squamous 48 invasive lobular 48 tamoxifen therapy 48 CD8 responses 48 methicillin resistant S. aureus 48 sexually transmitted virus 48 inactivated vaccines 48 Trichomonas 48 gliomas 48 squamous cell 48 molecular abnormalities 48 HBV genotype 48 herpes infection 48 slow metabolizers 48 murine leukemia virus 48 cSSSIs 48 vaccinia virus 48 lichen planus 48 HCV 48 Pentacel 48 PARP inhibition 48 KRAS mutation 48 SPINK1 48 postmenopausal breast cancer 48 BCR ABL 48 Candida infections 48 BRCA2 gene mutations 48 serous ovarian cancer 48 Hepatitis C virus HCV 48 FTC TDF 48 MRSA strains 48 reinfection 48 GSTT1 48 Chlamydia infections 48 Aldara 48 endometrial carcinoma 48 herpes zoster vaccine 48 antigen 48 recurrent genital herpes 48 influenza subtypes 48 gastrointestinal cancers 48 ovarian lung 48 medulloblastoma tumors 48 leukemias 48 S aureus 48 Gardasil 48 GSTP1 48 adenovirus serotype 5 48 HER2 expression 48 sexually transmitted infection 48 molecular subtypes 48 sporadic ALS 48 hepatitis B infection 48 peptide antigens 48 EBV infection 48 cervical carcinoma 48 chromosomal rearrangement 48 pre cancerous polyps 48 Papillomavirus 48 acellular pertussis 48 Testicular cancer 48 HBsAg 48 genetic variants associated 48 HER2 positive 48 Enterobacter cloacae 48 recurrent ovarian cancer 48 polio measles mumps rubella 48 spine fractures 48 HER-2/neu 48 UGT#A# * 48 proctitis 48 aneuploidy 48 Prevenar 48 histologic subtype 48 testicular germ cell 48 paramyxoviruses 48 vaccine Gardisil 48 Havrix 48 fluoroquinolone resistant 48 carbapenem resistant 48 trichomonas 48 antigen PSA 48 carcinoid tumors 48 pneumococcus bacteria 48 trivalent inactivated influenza 48 Streptococcus pneumoniae pneumococcus 48 pre cancerous growths 48 Hepatitis B Virus 48 ovarian endometrial 48 nelfinavir 48 premalignant lesions 48 Human Virus HPV 48 pituitary adenomas 48 EGFR inhibitors 48 lung tumors 48 vaccine TIV 48 SLNB 48 inherited predisposition 47 GBMs 47 malignancy 47 squamous cell skin 47 malignant pleural mesothelioma 47 chickenpox hepatitis B 47 spermicide nonoxynol 9 47 cervical neoplasia 47 HER2 positive tumors 47 BRCA2 carriers 47 HIV uninfected 47 metastases 47 squamous cell lung cancer 47 abnormal Pap 47 GNAQ 47 GBV C 47 capsular polysaccharides 47 USA# strain 47 Anal cancer 47 ErbB2 47 low expressors 47 chlamydia infections 47 Vaccine Diphtheria CRM# Protein 47 virologic responses 47 hepatocellular cancer 47 precancer 47 antibody titer 47 genital herpes 47 adenomas 47 pelvic malignancies 47 ependymomas 47 Menactra vaccine 47 tuberculin skin testing 47 nucleotide analog 47 neuraminidase inhibitor 47 PCV7 47 P. vivax malaria 47 vaccine Gardasil 47 malignant neoplasm 47 invasive pneumococcal infections 47 colorectal carcinoma 47 Pneumococcus 47 Malignant mesothelioma 47 vaccine Cervarix 47 HCV genotype 1 47 CIN3 47 chickenpox varicella 47 chromosomal abnormalities 47 cervical abnormalities 47 non Hodgkin lymphomas 47 tamoxifen 47 BRCA genes 47 Hepatocellular carcinoma 47 induces antibodies 47 gastrointestinal stromal tumors 47 S Typhi 47 SIV infection 47 invasive fungal infection 47 invasive fungal infections 47 VAX# 47 sarcosine 47 herpes zoster shingles 47 breast cancer susceptibility genes 47 IV bisphosphonates 47 MDR tuberculosis 47 dutasteride 47 Bordetella pertussis 47 Candida albicans 47 seasonal influenza 47 CTAP# Capsules 47 CMV 47 Staphylococcus aureus MRSA 47 VTE 47 pharyngeal cancer 47 metastatic tumors 47 oncogenes 47 Intercell vaccine 47 sentinel nodes 47 PTEN mutations 47 carcinoid 47 valacyclovir 47 KIF6 gene 47 hypereosinophilic syndrome 47 mutated genes 47 known teratogen substance 47 recombinant hepatitis B 47 vulvar cancers linked 47 Hybrid Capture 47 Epidermal Growth Factor Receptor 47 mycobacterium tuberculosis 47 iPrEx study 47 bacteria Neisseria meningitidis 47 TT genotype 47 Herceptin trastuzumab 47 Measles mumps 47 p# mutations 47 varicella vaccine 47 acellular pertussis DTaP 47 ocular toxicity 47 lung cancer NSCLC 47 pathogenic mutations 47 ErbB2 positive 47 antibody 47 ustekinumab 47 genotoxicity 47 Moraxella catarrhalis 47 undetectable viral loads 47 delayed CINV 47 Humenza 47 solar keratoses 47 tuberculosis bacterium 47 leukemia ALL 47 basal cell 47 thrombotic events 47 hormone therapy estrogen 47 viremia 47 pneumocystis 47 GeoVax vaccine 47 HIV infection 47 EGFR pathway 47 anovulatory infertility 47 genital tract infections 47 immunopathology 47 bacterium Mycobacterium tuberculosis 47 prostate adenocarcinoma 47 aneuploidies 47 HPV vaccine 47 lymph node metastases 47 hepatitis C infection 47 colorectal breast 47 C. sordellii 47 meningiomas 47 efalizumab 47 BRCA1 47 superficial bladder cancer 47 Drospirenone 47 alpha interferons 47 pre menopausal 47 Digene HPV Test 47 childhood leukemias 47 CA MRSA infections 47 BRCA2 gene mutation 47 diphtheria pertussis 47 UTIs 47 virologic failure 47 testicular cancers 47 Cristofanilli 47 thromboembolic events 47 pyogenes 47 adverse reactions incidence 47 exemestane 47 Hashimoto thyroiditis 47 NOXAFIL 47 lamivudine 47 antibody MAb 47 malignant tumors 47 armpit lymph nodes 47 vulvar intraepithelial neoplasia 47 periodontal bacteria 47 Haemophilus influenzae type 47 Li Fraumeni 47 lymphatic tissue 47 grade glioma 47 CYT# potent vascular disrupting 47 untreated celiac disease 47 CaP 47 M2e 47 Gardisil vaccine 47 BRCA2 gene 47 carcinoma 47 meningococcal conjugate 47 PARP inhibitors 47 Genital Warts 47 pancreatic lung 47 gonorrhea chlamydia 47 Pediarix 47 Latex condoms 47 measles virus 47 bacterial vaginosis BV 47 osteoporotic fracture 47 intestinal polyps 47 NKX2 47 PPSV# 47 recurrent UTIs 47 pCR 47 vaginal atrophy 47 colorectal carcinomas 47 human immunodeficiency virus 47 relapsed ovarian cancer 47 Measles Mumps 47 metastatic disease 47 IgM 47 chronic HCV 47 seroconverted 46 virus XMRV 46 pertussis Tdap vaccine 46 advanced neoplasia 46 latent tuberculosis infection 46 colorectal bladder 46 ADPKD 46 BiovaxID 46 Urinary tract infections UTIs 46 EGFR 46 varicella vaccines 46 rotavirus diarrhea 46 axillary node dissection 46 enterovirus 46 testicular tumors 46 malignant lymphoma 46 melanoma 46 HHV 6 46 MALT lymphoma 46 febrile neutropenia 46 abnormal Pap smear 46 Menomune 46 CCR5 tropic 46 non metastatic osteosarcoma 46 viral conjunctivitis 46 latent tuberculosis TB 46 Malignant Melanoma 46 microdeletions 46 heavily pretreated 46 RhD 46 immunocompromised patients 46 strep bacteria 46 nosocomial pneumonia 46 7F 9V 46 cisplatin resistant 46 intraepithelial neoplasia 46 genital human papillomavirus 46 vaccine LAIV 46 attenuated strain 46 H. influenzae 46 penicillin resistant 46 cytomegalovirus infection 46 tanned indoors 46 RotaTeq 46 heterosexual intercourse 46 P. aeruginosa 46 Bacille Calmette Guerin BCG 46 NRTI 46 PCV7 vaccine 46 gene BRCA2 46 HBV DNA 46 nosocomial infection 46 squamous cell carcinoma 46 polio hepatitis B 46 pilocytic astrocytomas 46 E. faecium 46 endometrial 46 prostate tumors 46 colorectal neoplasia 46 conserved antigens NP 46 CYT# NicQb 46 methicillin 46 HER2 protein 46 BCG vaccinated 46 Babesia 46 endometriosis ovarian cysts 46 benign growths 46 metachronous 46 chronic hepatitis 46 methylation markers 46 MVA#A 46 olaparib 46 Pertussis vaccine 46 distal colon cancer 46 germline mutations 46 breast pancreatic 46 daptomycin 46 nucleoside analogue 46 Francisella tularensis 46 leiomyomas 46 gonococcal infection